Navigation Links
Nextrials Wins the 2013 SCDM Data Driven Innovation Award for its EHR Integration Tool
Date:9/18/2013

(PRWEB) September 18, 2013

Nextrials, a leader in clinical research software and services, was the recipient of the 7th Annual Data Driven Innovation Award presented by the Society of Clinical Data Management at their annual meeting held in Chicago. Entries were vetted by a diverse team of judges representing all constituents of clinical data management including biopharmaceuticals and clinical technology. The final evaluation included a face-to-face live demo of the technology during the SCDM conference.

“We are very excited to be recognized for our work to utilize electronic health records for clinical research,” said Jim Rogers, co-founder and CEO of Nextrials. “Our commitment to the advancement of this technology includes 5 years of testing and validation at Connectathon conferences sponsored by the EHR standards organization, Integrating the Healthcare Enterprise (IHE). Our E2E tool is based on industry standards developed by IHE and the Clinical Data Interchange Standards Consortium (CDISC) and Nextrials is the only CDISC Registered Solutions Provider recognized for this standard. In addition to the functionality defined by the standard, we have added enhancements to better complement the research workflow including identification of data inconsistencies, handling of multiple data sources and subject enrollment directly from the EHR.”

Collecting clinical data directly from electronic health records has numerous benefits including the elimination of duplicate data and improving the timeliness of data. This new modality of clinical data collection is supported by regulatory agencies and is covered by guidances drafted by the FDA and the European Medicines Agency (EMA).

Read the full story at http://www.prweb.com/releases/2013/9/prweb11127803.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Linear Motor Driven Precision Linear Actuator from IntelLiDrives
2. Growing Uptake of Genzymes Aubagio at Three Months Post-Launch Is Likely Driven by Perceived Product Convenience Even As Neurologists Search to Identify Appropriate Candidates, According to a Recent BioTrends Report
3. Kitware to Enhance the Visualization Toolkit (VTK) to Accelerate Community-Driven Medical Innovation
4. 1DegreeBio Inc. Boosts Review-Driven Reagent Marketplace with New e-Commerce Platform
5. Enhanced Strategies for Design and Execution of Biomarker-driven Oncology Trials, new life science webinar hosted by Xtalks
6. A light wave of innovation to advance solar energy
7. Callibra, Inc. dba Discharge 1-2-3 is Named Winner of 2011 Chicago Innovation Award
8. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
9. The respective roles of the public and private sectors in pharmaceutical innovation
10. Nanoantennas show promise in optical innovations
11. Micross Components Hosts Stop on "Drive for Innovation" Tour
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
(Date:6/23/2016)... ... 2016 , ... In a new case report published today in STEM CELLS ... developed lymphedema after being treated for breast cancer benefitted from an injection of stem ... with this debilitating, frequent side effect of cancer treatment. , Lymphedema refers ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
(Date:3/29/2016)... RATON, Florida , March 29, 2016 ... or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are ... DNA in ink used in a variety of writing ... theft. Buyers of originally created collectibles from athletes on ... through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):